Challenges of Huntington's disease and quest for therapeutic biomarkers.

about

Single Cell Immuno-Laser Microdissection Coupled to Label-Free Proteomics to Reveal the Proteotypes of Human Brain Cells After Ischemia.Role of Dynein Axonemal Heavy Chain 6 Gene Expression as a Possible Biomarker for Huntington's Disease: a Translational Study.

P2860

Q47406994-AF877F50-796A-40A3-93DC-F67CA9C57998 Q47668176-D30792D3-502D-49A3-A368-D8EFB88147DD

P2860

Challenges of Huntington's disease and quest for therapeutic biomarkers.

Item

http://www.wikidata.org/entity/Q38257697

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Challenges of Huntington's disease and quest for therapeutic biomarkers.

@en

type

Item

label

Challenges of Huntington's disease and quest for therapeutic biomarkers.

@en

prefLabel

Challenges of Huntington's disease and quest for therapeutic biomarkers.

@en

P1476

Challenges of Huntington's disease and quest for therapeutic biomarkers

@en

P2093

Eva Kotrcova

http://www.w3.org/2001/XMLSchema#string

Hana Kovarova

http://www.w3.org/2001/XMLSchema#string

Ivona Valekova

http://www.w3.org/2001/XMLSchema#string

Jan Motlik

http://www.w3.org/2001/XMLSchema#string

Karla Jarkovska

http://www.w3.org/2001/XMLSchema#string

Suresh Jivan Gadher

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple Aspects of Gene Dysregulation in Huntington's Disease

Huntingtin's function in axonal transport is conserved in Drosophila melanogaster

Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice

Normal huntingtin function: an alternative approach to Huntington's disease

Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease

Neurological abnormalities in a knock-in mouse model of Huntington's disease

Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules

P304

147-158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PRCA.201400073

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martina Zizkova

P577

2014-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266625875

http://www.w3.org/2001/XMLSchema#string

P698

25290828

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

biomarker

Challenges of Huntington's disease and quest for therapeutic biomarkers.

about

P2860

P2860

Challenges of Huntington's disease and quest for therapeutic biomarkers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921